GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Affluent Medical (FRA:0JZ) » Definitions » Common Stock

Affluent Medical (FRA:0JZ) Common Stock : €3.32 Mil (As of Jun. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Affluent Medical Common Stock?

Affluent Medical's quarterly common stock declined from Jun. 2023 (€30.90 Mil) to Dec. 2023 (€3.09 Mil) but then increased from Dec. 2023 (€3.09 Mil) to Jun. 2024 (€3.32 Mil).

Affluent Medical's annual common stock increased from Dec. 2021 (€18.16 Mil) to Dec. 2022 (€20.75 Mil) but then declined from Dec. 2022 (€20.75 Mil) to Dec. 2023 (€3.09 Mil).


Affluent Medical Common Stock Historical Data

The historical data trend for Affluent Medical's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Affluent Medical Common Stock Chart

Affluent Medical Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Common Stock
Get a 7-Day Free Trial 11.90 15.26 18.16 20.75 3.09

Affluent Medical Semi-Annual Data
Dec16 Dec17 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 18.16 20.75 30.90 3.09 3.32

Affluent Medical Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.


Affluent Medical Business Description

Traded in Other Exchanges
Address
320, Avenue Archimede, Les Pleiades III, Batiment B, Aix-en-Provence, FRA, 13100
Affluent Medical is a medical device company. The company is developing, next-generation minimally invasive medical devices for the treatment of severe pathologies in urology and structural heart. The product portfolio of the company includes Artus, Kalios, Epygon, and Kardiozis. It has a single operating segment that conducts research and development of medical devices with a view to its future marketing.

Affluent Medical Headlines

No Headlines